No Cover Image

Journal article 246 views 51 downloads

Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices

Ana Alves, Shaun Green, Delyth James Orcid Logo

Pharmacy, Volume: 7, Issue: 3, Start page: 105

Swansea University Author: Delyth James Orcid Logo

  • 69696.VoR.pdf

    PDF | Version of Record

    © 2019 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

    Download (499.46KB)

Check full text

DOI (Published version): 10.3390/pharmacy7030105

Abstract

(1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale....

Full description

Published in: Pharmacy
ISSN: 2226-4787
Published: MDPI AG 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69696
first_indexed 2025-06-11T16:01:53Z
last_indexed 2025-07-08T04:59:41Z
id cronfa69696
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-07-07T16:35:15.6323678</datestamp><bib-version>v2</bib-version><id>69696</id><entry>2025-06-11</entry><title>Deprescribing of Medicines in Care Homes&#x2014;A Five-Year Evaluation of Primary Care Pharmacist Practices</title><swanseaauthors><author><sid>dc24cdd4d09d96fa49a0f213d1060cf9</sid><ORCID>0000-0001-7434-7064</ORCID><firstname>Delyth</firstname><surname>James</surname><name>Delyth James</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-06-11</date><deptcode>MEDS</deptcode><abstract>(1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to &#xA3;431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines.</abstract><type>Journal Article</type><journal>Pharmacy</journal><volume>7</volume><journalNumber>3</journalNumber><paginationStart>105</paginationStart><paginationEnd/><publisher>MDPI AG</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2226-4787</issnElectronic><keywords>care homes; deprescribing; pharmacists</keywords><publishedDay>3</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-08-03</publishedDate><doi>10.3390/pharmacy7030105</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>This research received no external funding; funding for the academic Masters fees during the feasibility study was received from NHS Health Education South West in 21st January 2015.</funders><projectreference/><lastEdited>2025-07-07T16:35:15.6323678</lastEdited><Created>2025-06-11T14:44:34.6067810</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Pharmacy</level></path><authors><author><firstname>Ana</firstname><surname>Alves</surname><order>1</order></author><author><firstname>Shaun</firstname><surname>Green</surname><order>2</order></author><author><firstname>Delyth</firstname><surname>James</surname><orcid>0000-0001-7434-7064</orcid><order>3</order></author></authors><documents><document><filename>69696__34695__6f47051ae0404a27834e153c931c43fd.pdf</filename><originalFilename>69696.VoR.pdf</originalFilename><uploaded>2025-07-07T16:32:47.1957160</uploaded><type>Output</type><contentLength>511448</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2019 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2025-07-07T16:35:15.6323678 v2 69696 2025-06-11 Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices dc24cdd4d09d96fa49a0f213d1060cf9 0000-0001-7434-7064 Delyth James Delyth James true false 2025-06-11 MEDS (1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to £431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines. Journal Article Pharmacy 7 3 105 MDPI AG 2226-4787 care homes; deprescribing; pharmacists 3 8 2019 2019-08-03 10.3390/pharmacy7030105 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University This research received no external funding; funding for the academic Masters fees during the feasibility study was received from NHS Health Education South West in 21st January 2015. 2025-07-07T16:35:15.6323678 2025-06-11T14:44:34.6067810 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Pharmacy Ana Alves 1 Shaun Green 2 Delyth James 0000-0001-7434-7064 3 69696__34695__6f47051ae0404a27834e153c931c43fd.pdf 69696.VoR.pdf 2025-07-07T16:32:47.1957160 Output 511448 application/pdf Version of Record true © 2019 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. true eng http://creativecommons.org/licenses/by/4.0/
title Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
spellingShingle Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
Delyth James
title_short Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
title_full Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
title_fullStr Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
title_full_unstemmed Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
title_sort Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
author_id_str_mv dc24cdd4d09d96fa49a0f213d1060cf9
author_id_fullname_str_mv dc24cdd4d09d96fa49a0f213d1060cf9_***_Delyth James
author Delyth James
author2 Ana Alves
Shaun Green
Delyth James
format Journal article
container_title Pharmacy
container_volume 7
container_issue 3
container_start_page 105
publishDate 2019
institution Swansea University
issn 2226-4787
doi_str_mv 10.3390/pharmacy7030105
publisher MDPI AG
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Pharmacy{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Pharmacy
document_store_str 1
active_str 0
description (1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to £431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines.
published_date 2019-08-03T05:27:40Z
_version_ 1851369623422763008
score 11.089572

Similar Items